bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.
With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, β-thalassemia and cerebral adrenoleukodystrophy. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward.
At bluebird bio, we are pursuing curative gene therapies to give patients and their families more bluebird days.
We have industry-leading clinical & research programs with a dedicated focus on severe genetic diseases. We custom design each of our therapies to address the underlying cause of disease & have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies & drive the field of gene therapy forward.